Immunic, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2014 - Q4(Jan 14 · Feb 14 · Mar 14)
Total Assets
$24M
↓-41.1% -$17Mvs FY2024
Total Liabilities
$31M
↑+36.9% +$8Mvs FY2024
Cash
$15M
↓-56.6% -$20Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $24M | $41M |
| Current Assets | $23M | $39M |
| Cash | $15M | $36M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $7M | $4M |
| Non-Current Assets | $1M | $2M |
| PPE | $608K | $545K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $575K | $991K |
| Total Liab+Eq | $24M | $41M |
| Current Liab. | $31M | $22M |
| Accounts Payable | $10M | $8M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $20M | $14M |
| Non-Current Liab. | $107K | $264K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $107K | $264K |
| Equity | $-7M | $18M |
| Retained Earnings | $609M | $511M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · IMUX · Comparing FY2025 vs FY2024